Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Lymphedema Treatment Companies

Lymphedema is a chronic condition characterized by the accumulation of lymphatic fluid, leading to swelling in certain parts of the body. Treatment often involves a combination of therapies, including compression garments, manual lymphatic drainage, exercise, and other interventions. Several companies specialize in providing products and services for the treatment of lymphedema.

Lymphedema Treatment Key Companies

Latest Lymphedema Treatment Companies Update

October 2023: Koya Medical, a healthcare organization dedicated to revolutionizing venous and lymphatic care via an all-encompassing collection of cutting-edge, patient-focused platforms, has introduced its Dayspring® active compression system for the treatment of lymphedema and venous disorders in the lower extremities into the marketplace in the United States. Additionally, the organization disclosed that the CMS had assigned three additional billing codes for the Dayspring active compression system, in accordance with the HCPCS. Dayspring is the first active dynamic compression treatment that has been approved by the U.S. Food and Drug Administration (FDA) without the use of pneumatics. It is wearable and is tailored specifically for the mobility of the patient. Dayspring enables patients to maintain their daily activities while undergoing treatment, in contrast to existing pneumatic (air-based) compression compressors that necessitate patient immobility and device plug-in to an outlet.

April 2023: AIROS® Medical, Inc., a manufacturer and designer of medical technology specializing in compression therapy devices for the treatment of lymphedema and venous complications, announced in April 2023 that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) to commercialize the AIROS 8P Sequential Compression Therapy garment system and device. In order to treat abdominal edema, the authorization also permits AIROS to offer larger compression therapy garments, such as lower truncal garments. By introducing the AIROS 8P pneumatic compression device and a new line of truncal garments, AIROS Medical will be able to treat a greater number of these patients. The pants-like construction of the truncal garment makes it an ideal garment for individuals afflicted with lymphedema affecting the lower thighs, back, abdomen, pelvis, and hips.

List of Lymphedema Treatment Key companies in the market

Mego Afek Ltd. (US)

Bio Compression Systems Inc. (US)

SIGVARIS (Switzerland)

Herantis Pharma PLC (Finland)

3A Health Care (Italy)

Wright Therapy Products (Germany)

Tactile Systems Technology Inc. (US)

Lohmann & Rausher (Germany)

Juzo (Germany)

3M (US)

Lymphedema Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.